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Abstract 
Mendelian randomisation studies from Asia suggest detrimental influences of alcohol on 
cardiovascular risk factors, but such associations are observed mainly in men. The absence of 
associations of genetics variants (e.g. rs671 in ALDH2) with such risk factors in women – 
who drank little in these populations – provides evidence that the observations are not due to 
genetic pleiotropy. Here, we present a Mendelian randomisation study in a South Korean 
population (3,365 men and 3,787 women) that 1) provides robust evidence that alcohol 
consumption adversely affects several cardiovascular disease risk factors, including blood 
pressure, waist to hip ratio, fasting blood glucose and triglyceride levels. Alcohol also 
increases HDL cholesterol and lowers LDL cholesterol. Our study also 2) replicates sex 
differences in associations which suggests pleiotropy does not underlie the associations, 3) 
provides further evidence that association is not due to pleiotropy by showing null effects in 
male non-drinkers, and 4) illustrates a way to measure population-level association where 
alcohol intake is stratified by sex. In conclusion, population-level instrumental variable 
estimation (utilizing interaction of rs671 in ALDH2 and sex as an instrument) strengthens 
causal inference regarding the largely adverse influence of alcohol intake on cardiovascular 
health in an Asian population.  
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Introduction 
Previous epidemiological studies have reported potential beneficial effects of moderate 
alcohol intake on cardiovascular health1,2. In a recent review paper combining results from 84 
observational studies, moderate drinkers were shown to have reduced risks of cardiovascular 
disease outcomes compared with non-drinkers, although heavy drinkers had the highest risks 
of all3. However, such evidence is not adequate for promotion of moderate alcohol use in 
prevention of heart disease given the known limitations of observational studies2,4. First, 
observed cardio-protective effects may be a form of reverse causation whereby individuals 
with the early stages of disease reduce their alcohol intake2,4,5. Second, observed effects 
might be due to confounding factors such as socioeconomic position, diet or other health-
related behaviours and therapeutic regimes4. Therefore, the causal nature of association 
beyond observed correlation must be investigated in order to fully evaluate the benefits or 
harms of alcohol use.  
Potential relationships should be interrogated through methods that can manipulate exposure 
and observe corresponding outcomes while accounting for confounding factors6. The gold 
standard is a randomised controlled trial (RCT), but this may be impossible to implement, 
prohibitively expensive or unethical. One alternative approach is that of Mendelian 
randomisation7. This method utilises a genetic variant that is allocated at conception in a 
manner that is independent of environment; people with the same genotype are thus akin to 
randomly allocated group of people in an RCT8. In essence, Mendelian randomisation 
exploits the idea such that a genetic variant, which proxies for the exposure, is expected to be 
related to the outcome to the degree anticipated given its association with the exposure. When 
Mendelian randomisation is implemented as a form of instrumental variable analysis, the 
genetic variant is referred to as an instrumental variable (IV)9. Using a Mendelian 
randomisation approach, causal effects of alcohol intake on cardiovascular outcomes have 
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been investigated in several studies5,10-12. Robust IVs for alcohol intake include genetic 
variants in aldehyde dehydrogenase 2 (ALDH2)13,14 and alcohol dehydrogenase 1B 
(ADH1B)10. Both these genes are involved in alcohol metabolism (Supplementary Fig. S1), 
although the ALDH2 variants have substantially more influence on alcohol intake than the 
ADH1B variants10. The ALDH2 variants are polymorphic mainly in East Asian populations 
(Supplementary Fig. S2).  Individuals who carry the variant allele experience on average 
greater discomfort after drinking alcohol, including nausea and facial flushing (so called 
Asian flush) since the variant allele codes for an inactive form of the enzyme, that leads to 
build-up of acetaldehyde in the circulation following alcohol consumption. As a result, 
carriage of the ALDH2 variant has consistently been linked with drinking behaviours15-19 and 
alcohol related diseases or risk factors in a number of Asian population studies11,15,20-26. For 
example, these studies consistently suggest that alcohol intake is associated with higher blood 
pressure21,24, not only in heavy drinkers but also in moderate drinkers11, corroborating some 
observational epidemiological studies3. Use of the variant also implies alcohol drinking is 
associated with coronary artery disease25 and coronary spastic angina26. On the other hand, 
some studies suggest alcohol drinking may have a favourable influence by increasing high 
density lipoprotein (HDL) cholesterol or decreasing low density lipoprotein (LDL) 
cholesterol11,22. However, these findings are not always robust10,25 and furthermore, the causal 
relationship between HDL cholesterol and cardiovascular health is uncertain27,28.  
For cardiovascular outcomes showing association with the ALDH2 variant, associations have 
largely been confined to Asian men5,21,24. Weak or null associations observed in Asian 
women are due to a low level of alcohol consumption in females irrespective of the genotype, 
which is analogous to the situation within a RCT framework where randomly allocated 
groups receiving a very low amount of exposure would not result in any difference in 
outcomes21. The difference of associations between men and women provides an excellent 
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rationale that the variant influences outcomes only through the exposure (i.e. alcohol intake), 
validating an assumption of Mendelian randomisation. The reasoning behind this is that if it 
were not the case – for example, if pleiotropic effects of the genetic variant influenced the 
outcomes - the same association between the variant and outcomes would have been seen in 
women as well as in men, as discussed in detail elsewhere5,20. Nevertheless, this sex 
stratification of alcohol intake also raises a question whether using the rs671 genotype alone 
as an IV would be sufficient to properly assesses causal effects in the whole population when 
both genetic variants and sex influences on alcohol intake should be considered29. 
In this study, we carried out a Mendelian randomisation study to investigate the causal effects 
of alcohol intake on a range of cardiovascular outcomes and included the stratification of 
alcohol intake by gender. Data were collected from a total of 7,152 individuals from South 
Korea, including 3,365 men and 3,787 women. First, causal effects of alcohol intake were 
investigated in men and women separately, by conventional IV models using the rs671 
genotype in ALDH2 as an IV. To demonstrate that the observed sex differences of association 
between the variant and cardiovascular outcomes were due to difference in corresponding 
drinking level rather than some particular influence of sex, the male-specific association was 
subsequently evaluated in sub-groups of never-drinkers and ever-drinkers. Finally, 
population-level causal effects were estimated by an extended IV model utilising interaction 
of the rs671 genotype and sex as an IV.  
 
Results 
General characteristics 
 4 
 
Basic characteristics of male and female participants are shown in Table 1. Mean values were 
different between men and women in most variables with the exception of hip circumference, 
total cholesterol, the rs671 genotype and genotypic principal components. Men were younger, 
more likely to live in urban areas, more educated, doing less exercise and smoking more than 
women on average. Alcohol intake was considerably higher in men than women; 72% of men 
were current drinkers compared to 26% of women; the average alcohol intake was 18.8 ± 0.5 
(g/day) in men and 1.3 ± 0.1 (g/day) in women; and gamma- glutamyl transpeptidase (GGT) 
was 55.4 ± 1.6 (IU/L) in men and 19.0 ± 0.3 (IU/L) in women. Men had higher prevalence of 
diseases and more generally unfavourable risk factors than women, although men had a few 
more generally favourable values as well (lower body mass index (BMI) and LDL 
cholesterol). It should be noted that there was no difference between men and women in the 
prevelance of rs671 genotype and genotypic principal components.  
Characteristics were also provided according to the rs671 genotype in each sex group (Table 
2). In both men and women, the rs671 genotype was in Hardy-Weinberg equilibrium with the 
A-allele frequency of 16%. The rs671 genotype was not associated with lifestyle or 
socioeconomic factors. Regarding alcohol intake, carriers of the rs671 A-allele had a lower 
proportion of current drinkers and consumed less alcohol than non-carriers in both men and 
women, though the magnitude of difference was bigger in men. With regard to disease 
prevalence and related risk factors, carriers of the rs671 A-allele appeared to have several 
potentially beneficial effects and a few potentially adverse effects than non-carriers (Table 2). 
All these associations were observed only in men and not in women. In addition to lifestyle 
or disease related factors, potential population stratification of the rs671 genotype was 
investigated through its association against the first five genotypic principal components. The 
second and the fourth principal components were correlated with the rs671 genotype in men 
(p=0.02) and women (p=0.04), respectively. Hence, these two principal components were 
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included in the subsequent Mendelian randomisation analysis to correct for population 
stratification.  
Next, the male population was divided into two groups by their drinking status: ever-drinkers 
and never-drinkers, and then corresponding characteristics in each group were provided 
according to the rs671 genotype (Table 3). In this stratified analysis, potential collider bias30 
was tested using generalized regression models with an interaction of genotype and drinking 
behaviour. Strong evidence of collider bias was observed for smoking behaviour (interaction 
p<0.0001) where its association with genotype by strata were in opposite directions (Table 3). 
To minimize the effect of risk factors susceptible to collider bias, associations between the 
rs671 genotypes and cardiovascular outcomes were then assessed with adjustments for 
smoking with the results being closely similar to those without adjustments. In male ever-
drinkers, the rs671 A-allele was associated with several potentially beneficial effects and a 
few potentially adverse effects after adjustments (Table 3). These associations were not 
observed in male never-drinkers, apart from weak associations with waist to hip ratio and 
fasting glucose level.        
 
Observational associations  
Association results based on the ordinary least squares (OLS) regression models can be found 
in Table 4 and Supplementary Tables S1. In men, alcohol intake was shown to be associated 
with higher hypertension risks, blood pressure, BMI, waist circumference, waist to hip ratio, 
log-transformed fasting blood glucose, HDL cholesterol, log-transformed triglycerides as 
well as with lower LDL cholesterol. In women, alcohol intake was associated with higher 
hypertension risks, blood pressure, BMI, hip circumference, log-transformed fasting glucose, 
total cholesterol and HDL cholesterol. The heterogeneity of OLS estimates in men and 
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women was observed for diastolic blood pressure, log-transformed fasting blood glucose and 
HDL cholesterol and marginally for hypertension, hip circumference and total cholesterol 
under the fixed effect model. All regression analysis results were inspected based on plots of 
the dependent variable against the independent variable as well as plots of residuals against 
fitted values. Neither nonlinear association (such as U shape association) nor a structured 
pattern of residual distribution was evident (data available on request).  
 
Causal estimates from Mendelian randomisation analysis  
Causal effects of alcohol intake on cardiovascular health and life style factors were inferred 
by IV estimation techniques (Table 5 and Supplementary Table S2). Corresponding causal 
relationships were also assessed through the association of the rs671 genotype with 
cardiovascular health and life style factors (Supplementary Tables S3 and S4). In men,  
alcohol intake, instrumented by the rs671 genotype, was  associated with higher risks of 
hypertension, blood pressure, waist circumference, waist to hip ratio, log-transformed fasting 
blood glucose, HDL cholesterol, and log-transformed triglycerides as well as with lower LDL 
cholesterol (all p<0.05). In women, there was little evidence for causal influences of alcohol 
intake on cardiovascular outcomes with an exception of hip circumference (p=0.035). The 
heterogeneity of IV estimates in men and women was observed for hip circumference 
(p=0.038) under the fixed effect model. 
Population-level causal effects were assessed as IV estimates where interaction of the rs671 
genotype and sex was used as an IV given that alcohol intake was stratified by sex as well in 
the whole population (Table 6). As a result, one unit of alcohol intake (g/day) was associated 
with higher hypertension risks, blood pressure, waist to hip ratio, log-transformed fasting 
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blood glucose, HDL cholesterol, log-transformed triglycerides as well as with lower LDL 
cholesterol at a population level.  
 
Discussion 
Here, we present a Mendelian randomisation study on alcohol intake and cardiovascular 
outcomes by analysing 7,152 individuals (3,365 men and 3,787 women) in South Korea. 
Causal influences of the exposure cannot be properly measured if the exposure level (alcohol 
intake, in this study) is indistinguishably low although there is a potentially valid IV (the 
rs671 genotype, in this study). For this reason, potential health outcomes consequent on 
alcohol drinking are not easily assessed in Asian women compared to Asian men5,21. We first 
replicated null or weakly observed association of the rs671 genotype and cardiovascular 
outcomes in women. Furthermore, we ensured such null association in women was not 
because of any female-specific biological mechanism but because of low drinking levels, by 
demonstrating analogous null association in male never-drinkers. The average alcohol intake 
level was 18.8 g/day in men and 1.3 g/day in women, and 22.9 g/day and 0.0 g/day in male 
ever- and never-drinkers.  
We quantified influences of alcohol intake on a wide range of cardiovascular outcomes by 
using instrumental variable estimation techniques. In men, one unit of alcohol intake (g/day), 
explained by the rs671 genotype, was associated with higher hypertension risks, and higher 
level of systolic blood pressure, diastolic blood pressure, waist circumference, fasting blood 
glucose, HDL cholesterol, triglycerides, and with lower LDL cholesterol. In women, none of 
these associations were observed as expected due to a very low alcohol intake. In the whole 
population, alcohol intake instrumented by interaction of the rs671 genotype and sex, 
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appeared to have the same effects on cardiovascular outcomes as in the male population, 
although the confidence intervals of the effect sizes were larger.  
Overall, we showed that alcohol intake is detrimental to most cardiovascular outcomes in the 
general Asian population as shown previously in Asian male populations11,31. The exception 
is high HDL cholesterol and low LDL cholesterol as they are generally considered favourable 
risk profiles with respect to cardiovascular health, although the protective role of high HDL 
cholesterol may not be fully established compared to that of low LDL cholesterol which has 
been supported by a number of Mendelian randomisation and RCT studies1,27,28,32.  
The credibility of the rs671 genotype in ALDH2 as an IV for alcohol intake has been 
discussed in many studies11,12,14,20,21. Biochemically, ALDH2 encodes the main enzyme in 
alcohol metabolism transferring toxic acetaldehyde, into non-toxic acetate. Simultaneously, it 
prevents another toxic chemical, aldehyde, from accumulating in the body. People carrying a 
mutated allele of this gene that produces an inactive form of the ALDH2 enzyme (which is 
the case mainly in Asians), experience discomfort after drinking such as facial flushing, 
nausea and a rapid heartbeat. This is likely to be underlying reason for the association 
between ALDH2 genotype and drinking behaviour.  
In our data, supporting evidence was found that the rs671 genotype in ALDH2 satisfied three 
core assumptions for an IV. First, it was independent of known confounders including age, 
education, residential area, physical activities and smoking status, both in men and women, as 
expected. Potential residual confounding by population stratification might exist to some 
extent, but we adjusted for genotypic principal components as covariates in the instrumental 
variable model. Second, it was strongly associated with alcohol intake (g/day) (F-statistic = 
262 in men and 38 even in women) confirming that it was an adequate IV unlikely to suffer 
weak instrument bias in this study. Furthermore, the rs671 genotype was also associated with 
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other directly relevant alcohol-related traits. That is, people with slow alcohol metabolism 
due to carriage of a mutated allele (rs671 A-allele) appeared to have lower proportion of ever 
and current drinkers as well as lower levels of GGT. GGT is often used as a biomarker for 
heavy drinking and the lower levels of GGT are likely to be influenced by drinking less 
alcohol as suggested in the latest study33. The third assumption required for instrumental 
variable analysis (that the ALDH2 genotype influences cardiovascular outcomes only through 
alcohol intake, in this study) is (like the assumption of no unmeasured confounding) 
impossible to validate. However, in this study, null effects in women provided evidence that 
it was unlikely that the estimated causal effects were due to pleiotropic effects; if there were 
pleiotropic effects, causal effects would have been observed in women as well as in men, as 
argued in detail elsewhere5,21. 
Several studies have previously reported the causal relationship between alcohol intake and 
cardiovascular outcomes10,11,20-23. One of main strengths of the current study lies in relatively 
accurate estimation of population-level causal effects of alcohol intake when the alcohol 
intake is stratified by gender. Instead of the genotype alone, we formally used interaction of 
the genotype and sex as an IV for alcohol for the first time to our knowledge. Secondly, we 
considered a broad spectrum of cardiovascular outcomes compared to previously studies in 
an Asian population. For example, Chen et al. reported a sex-specific causal effect of alcohol 
intake on systolic and diastolic blood pressures and hypertension21 in their meta-analysis 
based on results extracted from published data, whereas we estimated both sex-specific and 
population-level causal effects on 12 additional outcomes in as large as or larger samples in 
individual level data. In another previous study, Kato et al. reported a strong sex-specific 
association of the rs671 genotype and blood pressures22 and also showed that such 
association was mediated by alcohol intake implying a causal relationship between alcohol 
intake and blood pressures, but their approach was limited in terms of quantification of the 
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causal effects compared to the IV analysis that we applied in the current study. Finally it 
should be also mentioned that in a recent paper, Holmes et al. extensively covered the causal 
relationship of alcohol intake with various cardiovascular events and risk factors in the 
largest samples to date10; however, they used a different IV, the rs1229984 genotype in 
ADH1B which is known to be a much weaker IV than the rs671 genotype in ALDH2 we used, 
as the latter is not polymorphic in European individuals of their study. Therefore, our current 
study is one of the most comprehensive study providing robust causal effects of alcohol 
intake on cardiovascular health outcomes. Another interesting feature of this study may be 
that it is one of the first Mendelian randomisation studies quantifying causal effects in alcohol 
intake in the Korean population, although there exists a relevant observational study34. The 
Korean population was selected, not only because it is an Asian population carrying a 
mutated rs671-A allele in ALDH2, but also because the population level alcohol intake is 71% 
and 84% higher than Japan and China, respectively, ranking it as the country with the highest 
level of heavy drinking in Asia (based on the alcohol per capita consumption on average 
between 2008 and 2010 in the 2014 WHO report). Our results were, however, consistent with 
those in other instrumental variable based studies in Japan21 and China11. 
Nevertheless, our study has limitations. One of main limitation is the use of imputed 
genotype ALDH2 rs671 although the imputed genotype was generated by a standardised 
protocol. Genotypes were quality controlled prior to imputation (based on missing call rates, 
minor allele frequency, Hardy-Weinberg equilibrium and sex match) and publicly available 
reference datasets were used with commonly used and previously evaluated software35,36. In 
addition, imputed genotypes were evaluated based on imputation quality score and Hardy-
Weinberg equilibrium test. Thus, our imputed genotype would be as informative as a directly 
measured genotype, as shown in numerous genome-wide association studies. Also we 
acknowledge the limitation of the stratified analysis, as the stratification of the male 
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population on drinking behaviour history (ever vs. never drinkers) could introduce collider 
bias30. We identified a risk factor susceptible to collider bias in our data, and adjusted for its 
effect on associations between genotype and cardiovascular outcomes, which produced little 
change in the effect estimates.  
Despite providing evidence for a causal link between alcohol intake and a range of 
cardiovascular traits, our study did not observe clear causal effects of alcohol intake on 
cardiovascular disease or body mass index.  This is consistent with previous evidence, such 
as that provided by Au Yeung et al. who reported a null effect of alcohol intake on 
cardiovascular disease in Chinese men11,  although a recent meta-analysis by Holmes et al.10 
reported strong effects on both in individuals of European descent. One possible explanation 
is that our study and the study by Au Yeung et al.11 were underpowered to detect the causal 
effect as the samples sizes were much smaller than those accrued by Holmes et al. (7,152, 
and 4,500 compared with 260,000, respectively) 10. However, it is not straightforward to draw 
such conclusion yet because these studies have not only different sample sizes, but also 
different instruments (ALDH2 genotype being a stronger instrument than ADH1B genotype), 
different ethnic backgrounds (Korean and Chinese compared with European) and different 
methods were used to define cardiovascular disease (self- report and self- report compared 
with  combination of self- report, medical records, clinical/lab measures, death certificate and 
ICD code). Thus, a carefully designed large-scale study in well-phenotyped Asian population 
would be needed to further investigate this discrepancy.   
In conclusion, this study indicates that a reduction in alcohol intake may be beneficial to 
cardiovascular health through avoiding detrimental influences on cardiovascular risk factors.  
 
Methods 
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Study participants 
Subjects for the analysis were obtained from two population based studies within the Korean 
Genome and Epidemiology Study (KoGES), the rural Ansung and urban Ansan cohorts. 
Detailed information for each study has been described elsewhere37. Briefly, the Ansung-
Ansan cohorts were designed as longitudinal prospective studies initiated in 2001 and 
adopted the same investigational method. Participants in each cohort (5,018 in Ansung and 
5,020 in Ansan aged 39-70) were recruited using a two-stage cluster sampling method. All 
participants took part in a health examination, interviews, and laboratory tests. The current 
study was based on the baseline data collected in 2001 from a total of 7,152 participants 
having the rs671 genotype in ALDH2 available. All participants provided informed consent 
which was approved by the Human Subjects Review Committee at the Korea University 
Ansan Hospital or the Ajou University Medical Centre. The current study was approved by 
the Institute Review Board at the Korea University (KU-IRB-14-EX-153-A-1). 
 
Basic characteristics 
Information was collected on demographic characteristics including age, area, education, 
physical activity and current smoking status. Education level was divided into four groups: 
elementary school, middle school, high school, or university. Physical activity was divided 
into two groups: practice or do not practice, according to whether or not the individual 
participated in any of the following daily activity types; intense physical activity at least 20 
minutes, moderate physical activity at least 30 minutes, or walking at least 30 minutes. 
Current smokers were defined as a person who smoked cigarettes regularly at the time of the 
survey. 
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Alcohol traits 
Participants were also asked about their lifetime drinking behaviour, current drinking 
behaviour and detailed drinking behaviour over the previous 30 days, including frequency, 
amount and type of alcoholic beverages. Using this information along with average alcohol 
content of each beverage, total alcohol intake (g/day) was calculated. Further information on 
alcohol intake can be found in a previous publication38. As well as total alcohol intake (g/day), 
current drinking status, alcohol intake in current drinkers and GGT were considered as 
alcohol-related traits in this study. A current drinker was defined as an individual who drank 
alcoholic beverages regularly at the time of the survey. GGT concentration (IU/L) was 
measured from blood samples in the Seoul Clinical Laboratories (Seoul, Republic of Korea) 
collected after at least 8 hours of fasting. 
 
Blood pressure and other risk factors 
Blood pressure was measured in a sitting position with a mercury sphygmomanometers after 
at least 5 minutes of rest. Two acceptable measurements of blood pressure were obtained 
within a 1 minute interval and recorded to the nearest 2 mmHg. Average measurements for 
systolic and diastolic blood pressure were used for statistical analysis. Height (cm) and body 
weight (kg) were measured to the nearest 0.1 cm or 0.1 kg without shoes, from which BMI 
(kg/m2) was derived. Waist circumference (cm) was measured at the narrowest part between 
the lower rib and the iliac crest to the nearest 0.1 cm, and the average of 3 repeated 
measurements was calculated. Hip circumference was measured at the widest portion of the 
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buttocks to the nearest 0.1 cm, and the average of 3 repeated measurements was calculated. 
Waist to hip ratio was derived from waist circumference and hip circumference. 
 For laboratory tests, all participants had at least an 8 hour fasting period before blood 
collection. Collected blood samples were analysed in the Seoul Clinical Laboratories (Seoul, 
Republic of Korea) for assays including fasting blood glucose (mg/dL), total cholesterol 
(mg/dL), HDL cholesterol (mg/dL), and triglycerides (mg/dL). LDL cholesterol (mg/dL) was 
derived using the Friedewald formula39 in subjects with triglycerides less than 400mg/dL as 
follows; LDL cholesterol = total cholesterol– HDL cholesterol– (triglycerides / 5.0). For 
subjects with triglycerides of 400mg/dL or more, LDL cholesterol value was marked as 
missing. GGT concentration (IU/L) was measured from the same blood samples. 
 
Disease outcome 
According to health interview and examination, participants with self-reported diagnosed 
hypertension, use of blood pressure medicine, or measured systolic blood pressure greater 
than 140 mmHg, or diastolic blood pressure greater than 90 mmHg were considered as 
hypertensive. Cardiovascular disease status was defined by doctor-diagnosed and self-
reported questionnaire information on myocardial infarction, congestive heart failure, 
coronary artery disease, peripheral blood vessel disease, and cerebrovascular disease. A 
coronary heart disease event was additionally defined by the same questionnaire information 
but only on myocardial infarction and coronary artery disease. Diabetes was defined by 
doctor-diagnosed and self-reported questionnaire information.  
 
Genotyping quality control and imputation 
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Detailed information is provided elsewhere37. Briefly, DNA samples were isolated from the 
peripheral blood of participants and genotyped using the Affymetrix Genome-Wide Human 
SNP array 5.0 (Affymetrix, Inc., Santa Clara, CA, USA). The accuracy of the genotyping was 
calculated by Bayesian Robust Linear Modelling using the Mahalnobis Distance genotyping 
algorithm.40 A total of 352,228 SNPs in 8,842 participants became available after pre-
imputation QC, 1) excluding SNPs with high missing genotype call rates (> 5%), with minor 
allele frequency (MAF) < 0.01, and not in Hardy-Weinberg equilibrium (HWE, P value < 
1x10-6) and 2) removing samples with sex mismatch. Genetic principal components were 
computed in a subset of 304,225 SNPs after excluding additional 48,003 SNPs (not in HWE 
under a more conservative criterion, P value <1x10-5) through the EIGENSTRAT software 
package.41 
To impute rs671 ALDH2 genotype (http://www.ncbi.nlm.nih.gov/projects/SNP/), all 
genotypes in chromosome 12 were imputed using the 1000 Genomes Phase 1 v3 reference 
panel. The reference datasets of all populations were downloaded from the IMPUTE2 
website.35 To minimise the computational intensity and increase efficiency, genotypes were 
pre-phased with SHAPEIT36 prior to imputation by IMPUTE235 with the default options. As 
a post-imputation QC, SNPs were removed if MAF was low (< 0.05) or the imputation info 
value was low (< 0.8). As a result, the rs671 genotype in ALDH2 became available in a total 
of 7,152 participants with expected MAF of 0.194 and imputation info value of 0.845. 
 
Statistical analysis 
Statistical analyses were performed using Stata SE 12.0 (Stata Corp, Carollina, USA). First, 
the distribution of variable values was investigated. Fasting blood glucose, GGT and 
triglycerides were log-transformed to mimic a Gaussian distribution. No outliers were 
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detected by visual inspection. Descriptive statistics of all variable values were presented as 
mean ± standard error for a continuous variable, and as number of counts and percentage for 
a categorical variable in men and women separately, according to their rs671 genotype in 
ALDH2. Apart from major dependent variables (e.g. hypertension) and major independent 
variables (e.g. alcohol intake), some variables included missing data points. Mean difference 
of these variables in men and women was evaluated through Student’s t-test for a continuous 
variable and by chi-squared test for a categorical variable. Similarly, mean differences in 
these variables among three different rs671 genotype groups were compared using one-way 
analysis of variance (ANOVA) for a continuous variable and using chi-squared test for a 
categorical variable; in men and women, and in male ever-drinkers and male never-drinkers, 
separately. In addition, in order to evaluate potential collider stratification bias, the difference 
of variable distribution by genotype between male ever-drinkers and male never-drinkers was 
tested using generalized regression models which include rs671 genotype, drinking behaviour 
history (never vs. ever) and interaction of genotype and drinking behaviour history as the 
independent variables.  
The association between alcohol intake and other variables was assessed under an OLS 
regression model in men and women, separately. Continuous risk factors were predicted by 
alcohol intake under a linear regression model adjusting for potential confounding factors 
such as age, area, education, physical activity and smoking status. Hypertension, 
cardiovascular disease, coronary heart disease and diabetes were also predicted by alcohol 
intake under a logistic regression model adjusting for the same potential confounding factors. 
In order to investigate the potential violation of assumptions such as linearity of association 
and normality of the error distribution, plots of dependent variables against independent 
variables as well as plots of residuals against fitted values were generated. Results are 
presented as estimated regression coefficients β with 95% confidence interval (CI) for a 
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continuous variable, and estimated odds ratio (OR) with 95% CI for a categorical variable. 
Corresponding p-values are also provided. The difference of estimates between men and 
women was assessed by Cochran’s Q test using fixed effect models assuming the true effect 
of alcohol is the same in men and women.   
Lastly, the causal effect of alcohol intake on other variables was measured under an IV 
regression with a two stage least squares estimation method in men and women, separately, 
using the rs671 genotype as an instrument. For continuous risk factors, a two stage linear 
model was performed, with adjustments for age, area, education, physical activity and 
smoking status as well as additional adjustments for genotypic principal components to take 
into account population structure for the rs671 genotype. For hypertension and cardiovascular 
disease, a two stage logistic model was conducted; in the first stage, alcohol intake was 
predicted by rs671 genotype (with additive effect) under a linear regression model (adjusted 
for age, area, education, physical activity, smoking status and principal components); in the 
second stage, disease outcome was predicted by fitting the alcohol intake value from the first 
stage, under a logistic regression model (adjusted for the same potential confounding factors). 
Results were shown by providing estimated regression coefficients β with 95% CI for a 
continuous variable, and estimated OR, with 95% CI for a categorical variable along with 
corresponding p-values. The difference of estimates between men and women was assessed 
by Cochran’s Q test using fixed effect models assuming the true effect of alcohol is the same 
in men and women.   
The same causal effect was then quantified in the whole population, using interaction of the 
rs671 genotype and sex as an instrument. Instrumental variable regression models were 
additionally adjusted for the rs671 genotype and sex, the variables that were used to compute 
the interaction. It should be noted that interaction of the rs671 genotype and sex was used as 
an instrument even if the rs671 genotype was directly included in the model42.   
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Table 1. Characteristics of study participants  
  
All 
(N=7,152‡) 
Men 
(N=3,365‡) 
Women 
(N=3,787‡) 
P-value† 
Lifestyle and socio-economic factor*     
 Age (yrs) 52.3 ± 0.1 51.9 ± 0.2 52.7 ± 0.1 0.0002 
 Area (rural Ansung% / urban Ansan%)  47.2 / 52.8 43.1 / 56.9 50.8 / 49.2 <0.0001 
 
Education (elementary school% / middle 
school% / high school% / university%)  
33.2 / 22.9 /  
30.7 / 13.2 
19.7 / 22.4 /  
36.2 / 21.6 
45.1 / 23.3 /  
25.9 / 5.7 
<0.0001 
 Physical activity practitioner (%, N) 93.8 (6,609) 91.0 (3,027) 96.2 (3,582) <0.0001 
 Ever smoker (%, N) 40.9 (2,884) 80.5 (2,698) 5.0 (186) <0.0001 
 Current smoker (%, N) 22.2 (1,568) 44.2 (1,482) 2.3 (86) <0.0001 
Alcohol trait     
 Ever drinker (%, N) 54.3 (3,849) 82.5 (2,763) 29.1 (1,086) <0.0001 
 Current drinker (%, N) 47.8 (3,387) 72.4 (2,425) 25.7 (962) <0.0001 
 Former drinker (%, N) 6.5 (462) 10.1 (732) 3.3 (124) <0.0001 
 Never drinker (%, N) 45.7 (3,239) 17.5 (586) 71.0 (2,653) <0.0001 
 Alcohol intake (g/day) 9.6 ± 0.3 18.8 ± 0.5 1.3 ± 0.1 <0.0001 
 Alcohol intake in current drinkers (g/day) 20.2 ± 0.5 26.1 ± 0.6 5.2 ± 0.3 <0.0001 
 γ-glutamyl transpeptidase (IU/L)  36.1 ± 0.8 55.4 ± 1.6 19.0 ± 0.3 <0.0001 
Disease     
 Hypertension (%, N) 39.4 (2,816) 41.7 (1,404) 37.3 (1,412) <0.0001 
 Cardiovascular disease (%, N) 3.2 (228) 3.9 (130) 2.6 (98) 0.0020 
 Coronary heart disease (%, N) 1.7 (122) 2.1 (72) 1.3 (50) 0.008 
 Diabetes (%, N) 7.1 (504) 8.3 (278) 6.0 (226) <0.0001 
Cardiovascular risk factor     
 Systolic blood pressure (mmHg) 124.9 ± 0.2 125.7 ± 0.3 124.1 ± 0.3 0.0004 
 Diastolic blood pressure (mmHg) 81.7 ± 0.1 83.4 ± 0.2 80.2 ± 0.2 <0.0001 
 Body mass index (kg/m2) 24.59 ± 0.04 24.24 ± 0.05 24.90 ± 0.05 <0.0001 
 Waist circumference (cm) 82.7 ± 0.1 83.7 ± 0.1 81.8 ± 0.2 <0.0001 
 Hip circumference (cm) 93.6 ± 0.1 93.6 ± 0.1 93.7 ± 0.1 0.6282 
 Waist to hip ratio (continuous) 0.883 ± 0.001 0.894 ± 0.001 0.873 ± 0.001 <0.0001 
 Fasting blood glucose (mg/dL) 87.7 ± 0.3 90.6 ± 0.4 85.0 ± 0.3 <0.0001 
 Total cholesterol (mg/dL) 191.9 ± 0.4 192.0 ± 0.6 191.8 ± 0.6 0.7511 
 HDL cholesterol (mg/dL) 44.7 ± 0.1 43.8 ± 0.2 45.5 ± 0.2 <0.0001 
 LDL cholesterol (mg/dL)  115.8 ± 0.4 114.5 ± 0.6 116.9 ± 0.5 0.0021 
 Triglycerides (mg/dL)  164.2 ± 1.3 179.9 ± 2.1 150.2 ± 1.5 <0.0001 
Genotype     
 rs671 in ALDH2 (GG% /GA% /AA%) 71.0 / 26.2 / 2.7 71.2 / 26.0 / 2.9 70.9 / 26.5 / 2.6 0.7810 
Population stratification indicator     
 Height (cm) 160.0 ± 0.1 166.9 ± 0.1 153.8 ± 0.1 <0.0001 
 Principal component 1 (continuous) 0.0019 ± 0.0025 -0.0003±0.0037 0.0038 ± 0.0034 0.4200 
 Principal component 2 (continuous) 0.0001 ± 0.0024 0.0001 ± 0.0036 0.0001 ± 0.0033 0.9956 
 Principal component 3 (continuous) -0.0013 ±0.0023 -0.0005 ±0.0034 -0.0020 ±0.0032 0.7419 
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 Principal component 4 (continuous) -0.0013 ±0.0020 -0.0015 ±0.0029 -0.0012 ±0.0028 0.9382 
 Principal component 5 (continuous) -0.0016 ±0.0020 -0.0033 ±0.0029 -0.0001 ±0.0027 0.4252 
 
*Values are represented as mean ± standard error for continuous variables and number of counts and percent
age for categorical variables. †P-values are from student’s t-test for continuous variables and chi-squared test
 for categorical variables assessing the difference between males and females. ‡Apart from major dependent 
variables (e.g. hypertension) and major independent variables (e.g. alcohol intake), some variables included 
missing data points. 
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Table 2. Characteristics of study participants according to their rs671 genotype in ALDH2 
  Men 
(N=3,365‡) 
 Women 
(N=3,787‡) 
  G/G 
(N=2,395) 
G/A 
(N=874) 
A/A 
(n=96) 
P-value† 
 G/G 
(N=2,684) 
G/A 
(N=1,003) 
A/A 
(N=100) 
P-value† 
Lifestyle and socio-economic factor*          
 Age (yrs) 51.8 ± 0.2 52.1 ± 0.3 51.6 ± 0.9 0.6015  52.6 ± 0.2 52.6 ± 0.3 53.3 ± 0.8 0.7561 
 Area (rural Ansung % / urban Ansan%)  43.8 / 56.2 40.7 / 59.3 45.8  / 54.2 0.2430  51.6 / 48.4 49.2 / 50.9 45.0 / 55.0 0.2030 
 
Education (elementary school % / middle 
school % /  high school % / university%)  
20.5 / 21.9 /  
36.1 / 21.5 
17.7 / 23.1 /  
37.1 / 22.1 
19.0 / 29.5 /  
30.5 / 21.1 
0.3860 
 46.1 / 23.4 / 
 25.0 / 5.6 
42.6 / 23.4 / 
 27.5 / 6.6 
45.5 / 19.2 / 
 33.3 / 2.0 
0.1150 
 Physical activity practioner (%, N) 91.6 (2,165) 90.0 (780) 87.2 (82) 0.1540  96.1 (2,538) 96.3 (947) 98.0 (97) 0.5950 
 Ever smoker (%, N) 80.7 (1,923) 80.9 (704) 74.0 (71) 0.2520  5.4 (142) 4.2 (41) 3.1 (3) 0.2110 
 Current smoker (%, N) 44.6 (1,062) 44.1 (384) 37.5 (36) 0.3940  2.4 (64) 2.0 (20) 2.0 (2) 0.7710 
Alcohol trait          
 Ever drinker (%, N) 93.0 (2,220) 60.7 (527) 16.8 (16) <0.0001  35.6 (943) 14.3 (142) 1.0 (1) <0.0001 
 Current drinker (%, N) 82.9 (1,979) 50.4 (437) 9.5 (9) <0.0001  31.6 (837) 12.5 (124) 1.0 (1) <0.0001 
 Former drinker (%, N) 10.1 (241) 10.4 (90) 7.4 (7) 0.6540  4.0 (106) 1.8 (18) 0 (0) 0.0010 
 Never drinker (%, N) 7.0 (166) 39.3 (341) 83.2 (79) <0.0001  64.4 (1,705) 85.7 (849) 99.0 (99) <0.0001 
 Alcohol intake (g/day) 23.78 ± 0.63 7.28 ± 0.59 0.41 ± 0.20 <0.0001  1.70 ± 0.13 0.41 ± 0.11 0.02 ± 0.02 <0.0001 
 Alcohol intake in current drinkers (g/day) 28.8 ± 0.7 14.6 ± 1.1 4.3 ± 1.7 <0.0001  5.4 ± 0.4 3.3 ± 0.8 2.3§ 0.1186 
 γ-glutamyl transpeptidase (IU/L) 62.6 ± 2.1 38.6 ± 1.8 26.1 ± 2.0 <0.0001  19.5 ± 0.4 17.6 ± 0.5 17.6 ± 1.6 0.0095 
Disease          
 Hypertension (%, N) 43.8 (1,050) 36.8 (322) 33.3 (32) <0.0001  37.8 (1,014) 36.2 (363) 35.0 (35) 0.6010 
 Cardiovascular disease (%, N) 3.6 (87) 4.6 (40) 3.1 (3) 0.4290  2.7 (71) 2.6 (26) 1.0 (1) 0.5960 
 Coronary heart disease (%, N) 2.0 (48) 2.6 (23) 1.0 (1) 0.4110  1.2 (33) 1.6 (16) 1.0 (1) 0.6610 
 Diabetes (%, N) 8.9 (212) 6.9 (60) 6.3 (6) 0.1460  6.0 (160) 5.9 (59) 7.0 (7) 0.9040 
Cardiovascular risk factor          
 Systolic blood pressure (mmHg) 126.5 ± 0.4 123.9 ± 0.6 123.2 ± 1.7 0.0003  124.1 ± 0.4 124.3 ± 0.6 123.8 ± 2.0 0.9553 
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 Diastolic blood pressure (mmHg) 83.9 ± 0.2 82.3 ± 0.4 83.0 ± 1.1 0.0015  80.2 ± 0.2 80.2 ± 0.4 79.7 ± 1.1 0.9151 
 Body mass index (kg/m2) 24.3 ± 0.1 24.2 ± 0.1 23.8 ± 0.3 0.1949  24.9 ± 0.1 24.8 ± 0.1 24.9 ± 0.4 0.4150 
 Waist circumference (cm) 83.9 ± 0.2 83.2 ± 0.3 82.0 ± 0.7 0.0066  82.0 ± 0.2 81.3 ± 0.3 81.1 ± 1.0 0.1195 
 Hip circumference (cm) 93.6 ± 0.1 93.7 ± 0.2 93.0 ± 0.5 0.4840  93.8 ± 0.1 93.5 ± 0.2 93.3 ± 0.6 0.3782 
 Waist to hip ratio (continuous) 0.897 ± 0.001 0.888 ± 0.002 0.880 ± 0.005 <0.0001  0.874 ± 0.002 0.870 ± 0.003 0.869 ± 0.008 0.3304 
 Fasting blood glucose (mg/dL) 91.8 ± 0.5 88.3 ± 0.7 83.3 ± 1.3 <0.0001  84.9 ± 0.3 85.2 ± 0.7 86.7 ± 2.4 0.6904 
 Total cholesterol (mg/dL) 191.8 ± 0.8 192.9 ± 1.2 190.5 ± 3.7 0.6971  191.3 ± 0.7 192.9 ± 1.1 192.3 ± 3.7 0.4741 
 HDL cholesterol (mg/dL) 44.6 ± 0.2 41.8 ± 0.3 40.3 ± 0.8 <0.0001  45.6 ± 0.2 45.2 ± 0.3 46.1 ± 1.0 0.3771 
 LDL cholesterol (mg/dL) 112.4 ± 0.7 119.4 ± 1.1 120.4 ± 3.4 <0.0001  116.4 ± 0.6 118.2 ± 1.0 117.2 ± 3.0 0.3131 
 Triglycerides (mg/dL) 186.2 ± 2.6 166.0 ± 3.5 151.1 ± 7.9 <0.0001  149.0 ± 1.7 153.2 ± 3.1 150.6 ± 8.4 0.4184 
Population stratification indicator          
 Height (cm) 167.0 ± 0.1 166.8 ± 0.2 166.0 ± 0.6 0.2223  153.8 ± 0.1 153.8 ± 0.2 153.2 ± 0.5 0.5572 
 Principal component 1 (continuous) 0.017 ± 0.004 -0.005 ± 0.007 -0.006 ± 0.023 0.7174  0.003 ± 0.004 0.002 ± 0.007 0.046 ± 0.020 0.1273 
 Principal component 2 (continuous) -0.006 ± 0.004 0.015 ± 0.007 0.021 ± 0.020 0.0203  0.002 ± 0.004 -0.003 ±0.006 -0.016 ±0.023 0.5925 
 Principal component 3 (continuous) -0.002 ± 0.004 0.004 ± 0.007 -0.009 ± 0.023 0.6787  -0.001 ±0.004 -0.005 ±0.007 -0.006 ±0.020 0.8225 
 Principal component 4 (continuous) -0.003 ± 0.003 0.003 ± 0.006 -0.008 ± 0.017 0.6504  0.0001±0.0033 -0.0083±0.0054 0.0359±0.0195 0.0389 
 Principal component 5 (continuous) -0.001 ± 0.003 -0.007 ± 0.006 -0.018 ± 0.016 0.5092  0.0003±0.0032 -0.0018±0.0055 0.0056±0.0166 0.8872 
 
*Values are represented as mean ± standard error for continuous variables and number of counts and percentage for categorical variables. †P-values are from AN
OVA test for continuous variables and chi-squared test for categorical variables assessing the difference among G/G, G/A and A/A genotype groups. ‡Apart fro
m major dependent variables (e.g. hypertension) and major independent variables (e.g. alcohol intake), some variables included missing data points. §There is o
nly one current drinker in the female A/A group. 
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Table 3. Characteristics of male participants according to drinking behaviour history and the rs671 genotype in ALDH2 
  Ever drinkers in men 
(N=2,763‡) 
 Never drinkers in men 
(N=586‡) 
 
Men 
(N=3,349††) 
  
G/G 
(N=2,220) 
G/A 
(N=527) 
A/A 
(N=16) 
P-value† 
Adjusted 
P-value‡ 
 
G/G 
(N=166) 
G/A 
(N=341) 
A/A 
(N=79) 
P-value† 
Adjusted 
P-value‡ 
Genotype*drinking 
behaviour history 
interaction p-value§ 
Lifestyle and socio-economic factor*              
 Age (yrs) 51.7 ± 0.2 51.5 ± 0.4 51.2 ± 2.3 0.8668 0.548  52.1 ± 0.7 52.9 ± 0.5 51.7 ± 1.0 0.4405 0.974  0.978 
 Area (rural Ansung% / urban 
Ansan%)  
43.9 / 56.1 40.4 / 59.6 31.3 / 68.8 0.2230 0.112 
 
41.6 / 58.4 40.5 / 59.5 48.1 / 51.9 0.4630 0.904 
 
0.475 
 
Education (elementary school% / 
middle school% / high school% / 
university%)  
20.6 / 22.0 /  
36.4 / 20.9 
16.9 / 20.5 /  
37.8 / 24.7 
25.0 / 25.0 /  
25.0 / 25.0 
0.2840 0.032 
 19.4 / 19.4 /  
32.1 / 29.1 
18.6 / 26.8 / 
 36.6 / 18.0 
18.0 / 29.5 / 
 32.1 / 20.5 
0.1070 0.615 
 
0.147 
 Physical activity practitioner (%, N) 91.5 (2,016) 91.4 (480) 81.3 (13) 0.3440 0.532  92.5 (147) 87.9 (297) 88.3 (68) 0.2970 0.327  0.209 
 Ever smoker (%, N) 52.6 (1,167) 51.3 (270) 37.5 (6) 0.4260 -  15.1 (25) 42.4 (144) 43.0 (34) <0.0001 -  <0.0001 
 Current smoker (%, N) 46.9 (1,039) 47.9 (252) 31.3 (5) 0.4100 -  13.3 (22) 38.2 (130) 39.2 (31) <0.0001 -  <0.0001 
Alcohol trait              
 Alcohol intake (g/day) 25.6 ± 0.7 12.1 ± 0.9 2.4 ± 1.1 <0.0001 <0.0001  0 0 0 - -  - 
 γ-glutamyl transpeptidase (IU/L) 65.0 ± 2.2 43.8 ± 2.6 28.3 ± 3.3 <0.0001 <0.0001  29.3 ± 2.0 30.8 ± 2.3 25.8 ± 2.4 0.6193 0.194  0.525 
Disease              
 Hypertension (%, N) 44.3 (984) 39.1 (206) 37.5 (6) 0.0830 0.018  36.1 (60) 33.1 (113) 31.7 (25) 0.7270 0.863  0.437 
 Cardiovascular disease (%, N) 3.6 (80) 4.8 (25) 0 (0) 0.3380 0.412  4.2 (7) 4.4 (15) 3.8 (3) 0.9710 0.735  0.925 
 Coronary heart disease (%, N) 2.1 (46) 3.0 (16) 0 (0) 0.3350 0.312  1.2 (2) 2.1 (7) 1.3 (1) 0.7470 0.919  0.806 
 Diabetes (%, N) 9.0 (199) 6.1 (32) 18.8 (3) 0.0340 0.125  7.8 (13) 7.9 (27) 3.8 (3) 0.4310 0.563  0.363 
Cardiovascular risk factor              
 Systolic blood pressure (mmHg) 126.6 ± 0.4 124.1 ± 0.7 121.5 ± 3.5 0.0091 0.001  124.5 ± 1.3 123.4 ± 0.9 123.3 ± 1.9 0.7471 0.904  0.537 
 Diastolic blood pressure (mmHg) 84.0 ± 0.2 83.2 ± 0.5 83.3 ± 2.1 0.3322 0.103  82.4 ± 0.9 80.9 ± 0.6 82.7 ± 1.2 0.1825 0.730  0.763 
 Body mass index (kg/m2) 24.3 ± 0.1 24.4 ± 0.1 24.3 ± 0.8 0.9063 0.796  24.3 ± 0.2 23.9 ± 0.2 23.6 ± 0.3 0.2405 0.269  0.087 
 Waist circumference (cm) 84.0 ± 0.2 83.8 ± 0.3 83.0 ± 2.1 0.8190 0.527  83.8 ± 0.6 82.3 ± 0.4 81.7 ± 0.8 0.0800 0.064  0.024 
 Hip circumference (cm) 93.6 ± 0.1 94.1 ± 0.2 95.4 ± 1.3 0.0793 0.045  93.7 ± 0.5 93.1 ± 0.3 92.5 ± 0.6 0.3337 0.347  0.131 
 Waist to hip ratio (continuous) 0.897 ± 0.001 0.891 ± 0.003 0.869 ± 0.015 0.0156 0.008  0.895 ± 0.005 0.883 ± 0.003 0.881 ± 0.006 0.1013 0.047  0.044 
 Fasting blood glucose (mg/dL) 91.9 ± 0.6 88.5 ± 0.8 84.9 ± 3.8 0.0081 0.001  91.5 ± 2.5 88.1 ± 1.1 83.1 ± 1.4 0.0267 0.044  0.011 
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 Total cholesterol (mg/dL) 192.0 ± 0.8 194.0 ± 1.6 195.1 ± 11.0 0.5228 0.301  189.2 ± 2.9 191.4 ± 1.9 190.0 ± 4.0 0.7988 0.840  0.751 
 HDL cholesterol (mg/dL) 44.9 ± 0.2 42.6 ± 0.4 38.6 ± 1.9 <0.0001 <0.0001  40.6 ± 0.7 40.4 ± 0.5 40.8 ± 1.0 0.9372 0.628  0.995 
 LDL cholesterol (mg/dL) 112.1 ± 0.7 119.1 ± 1.5 121.5 ± 9.3 0.0001 <0.0001  117.7 ± 2.6 120.2 ± 1.7 120.6 ± 3.7 0.6746 0.526  0.455 
 Triglycerides (mg/dL) 187.7 ± 2.8 170.9 ± 4.7 178.9 ± 29.2 0.0093 0.003  164.7 ± 9.3 158.8 ± 5.1 145.5 ± 7.5 0.7895 0.410  0.660 
Population stratification indicator              
 Height (cm) 167.0 ± 0.1 167.1 ± 0.3 168.4 ± 1.4 0.6236 0.576  166.6 ± 0.5 166.4 ± 0.3 165.6 ± 0.6 0.4222 0.146  0.247 
 Principal component 1 (continuous) 0.0002±0.0045 -0.012±0.010 0.053±0.056 0.3130 0.491  0.022 ± 0.016 0.007±0.011 -0.016±0.026 0.4140 0.198  0.198 
 Principal component 2 (continuous) -0.006±0.004 0.009±0.009 0.029±0.049 0.2839 0.128  -0.018±0.017 0.024±0.011 0.015±0.022 0.1008 0.091  0.097 
 Principal component 3 (continuous) -0.001±0.004 -0.002±0.008 -0.055±0.056 0.5542 0.668  -0.023±0.015 0.014±0.011 0.003±0.026 0.1446 0.223  0.164 
 Principal component 4 (continuous) -0.003±0.004 0.001±0.007 -0.033±0.041 0.7007 0.855  0.002±0.014 0.005±0.010 -0.007±0.019 0.8614 0.425  0.806 
 Principal component 5 (continuous) -0.002±0.004 -0.004±0.007 0.016±0.029 0.9005 0.998  0.015±0.013 -0.011±0.009 -0.025±0.018 0.1605 0.074  0.060 
  
*Values are represented as mean ± standard error for continuous variables and number of counts percentage for categorical variables. †P-values are from ANOV
A test for continuous variables and chi-squared test for categorical variables assessing the difference among G/G, G/A and A/A genotype groups. ‡Adjusted p-va
lues are from linear regression for continuous variables and logistic regression for categorical variables assessing the difference among G/G, G/A and A/A genot
ype groups, after adjustments for smoking behaviour (never/previous/current). §P-values of interaction between genotype and drinking behaviour history (never 
vs. ever drinkers) are from generalized regression models. ††In men with drinking behaviour history available, some variables included missing data points apart
 from major dependent variables (e.g. hypertension) and major independent variables (e.g. alcohol intake). 
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Table 4. Ordinary least squares estimates of alcohol intake (g/day) to cardiovascular health outcomes  
  Men 
(N=3,365‡) 
Women 
(N=3,787‡) Heterogeneity 
P-value† 
 
 OR (95% CI) 
by OLS estimation* 
P-value 
OR (95% CI) 
by OLS estimation* 
P-value 
Disease       
 Hypertension 1.007 (1.005, 1.010) <0.0001 1.021 (1.008, 1.035) 0.002 0.048 
 Cardiovascular disease 0.995 (0.988, 1.003) 0.266 1.008 (0.976, 1.041) 0.618 0.937 
 Coronary heart disease  1.001 (0.992, 1.009) 0.868 1.018 (0.989, 1.047) 0.231 0.274 
 Diabetes 0.999 (0.994, 1.004) 0.756 1.002 (0.974, 1.030) 0.914 0.843 
 
Beta coefficient (95% CI) 
by OLS estimation* 
P-value 
Beta coefficient (95% CI) 
by OLS estimation* 
P-value  
Cardiovascular risk factor       
 Systolic blood pressure (mmHg) 0.075 (0.055, 0.095) <0.0001 0.159 (0.061, 0.258) 0.002 0.099 
 Diastolic blood pressure (mmHg) 0.049 (0.035, 0.062) <0.0001 0.154 (0.091, 0.216) <0.0001 0.001 
 Body mass index (kg/m2) 0.004 (0.001, 0.008) 0.017 0.020 (0.003, 0.038) 0.024 0.104 
 Waist circumference (cm) 0.022 (0.012, 0.031) <0.0001 0.046 (-0.001, 0.093) 0.054 0.328 
 Hip circumference (cm) 0.0057 (-0.0004, 0.0117) 0.068 0.0388 (0.0072, 0.0704) 0.016 0.043 
 Waist to hip ratio (continuous) 0.0002 (0.0001, 0.0002) <0.0001 0.0002 (-0.0002, 0.0005) 0.386 0.869 
 Log-transformed fasting blood glucose (log(mg/dL)) 0.0004 (0.0003, 0.0005) <0.0001 0.0004 (0.0000, 0.0008) 0.043 <0.0001 
 Total cholesterol (mg/dL) 0.010 (-0.033, 0.052) 0.659 0.207 (0.017, 0.396) 0.033 0.048 
 HDL cholesterol (mg/dL) 0.059 (0.047, 0.071) <0.0001 0.196 (0.142, 0.251) <0.0001 <0.0001 
 LDL cholesterol (mg/dL) -0.130 (-0.170, -0.090) <0.0001 -0.023 (-0.191, 0.145) 0.786 0.226 
 Log-transformed triglycerides (log(mg/dL)) 0.0010 (0.0008, 0.0013) <0.0001 0.0005 (-0.0006, 0.0015) 0.393 0.327 
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*OR and beta coefficients by OLS estimation were obtained from standard regressions with an ordinary least squares estimation method (in logistic regression 
models and in linear regression models, respectively). All regression models were adjusted for age, area, education, physical activity and smoking status. 
†Heterogeneity in estimates between males and females was assessed by Cochran’s Q test with fixed effects. ‡Apart from major dependent variables (e.g. 
hypertension) and major independent variables (e.g. alcohol intake), some variables included missing data points.  
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Table 5. Instrumental variable estimates of alcohol intake (g/day) to cardiovascular health outcomes, based on the rs671 genotype in ALDH2 
  Men 
(N=3,365‡) 
Women 
(N=3,787‡) Heterogeneity  
P-value† 
  
 OR (95% CI) 
by IV estimation* 
P-value 
OR (95% CI) 
by IV estimation* 
P-value 
Disease       
 Hypertension  1.020 (1.010, 1.029) <0.0001 1.042 (0.921, 1.178) 0.516 0.736 
 Cardiovascular disease  0.990 (0.968, 1.013) 0.390 1.206 (0.827, 1.759) 0.331 0.397 
 Coronary heart disease  0.994 (0.965, 1.024) 0.705 0.996 (0.614, 1.616) 0.988 0.994 
 Diabetes 1.018 (1.000, 1.036) 0.053 0.968 (0.768, 1.220) 0.783 0.662 
 
Beta coefficient (95% CI) 
by IV estimation* 
P-value 
Beta coefficient (95% CI) 
by IV estimation* 
P-value   
Cardiovascular risk factor       
 Systolic blood pressure (mmHg) 0.159 (0.085, 0.234) <0.0001 -0.352 (-1.292, 0.589) 0.464 0.289 
 Diastolic blood pressure (mmHg) 0.085 (0.035, 0.135) 0.001 -0.109 (-0.701, 0.483) 0.718 0.522 
 Body mass index (kg/m2) 0.012 (-0.001, 0.025) 0.061 0.098 (-0.079, 0.274) 0.277 0.340 
 Waist circumference (cm) 0.060 (0.026, 0.094) 0.001 0.425 (-0.058, 0.909) 0.085 0.140 
 Hip circumference (cm) 0.005 (-0.017, 0.028) 0.633 0.358 (0.025, 0.690) 0.035 0.038 
 Waist to hip ratio (continuous) 0.0006 (0.0004, 0.0008) <0.0001 0.0012 (-0.0023, 0.0047) 0.501 0.739 
 Log-transformed fasting blood glucose (log(mg/dL)) 0.0010 (0.0006, 0.0014) <0.0001 -0.0014 (-0.0052, 0.0025) 0.494 0.253 
 Total cholesterol (mg/dL) -0.040 (-0.196, 0.116) 0.614 -0.897 (-2.817, 1.023) 0.360 0.383 
 HDL cholesterol (mg/dL) 0.170 (0.124, 0.216) <0.0001 0.266 (-0.278, 0.810) 0.338 0.731 
 LDL cholesterol (mg/dL) -0.405 (-0.552, -0.258) <0.0001 -1.007 (-2.702, 0.688) 0.244 0.488 
 Log-transformed triglycerides (log(mg/dL)) 0.002 (0.001, 0.003) <0.0001 -0.007 (-0.018, 0.004) 0.222 0.139 
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*OR and beta coefficient by IV estimation were obtained from instrumental variable regressions with a two stage least squares estimation method (in logistic 
regression models and in linear regression models, respectively), using rs671 genotype as an instrument for alcohol intake. All regression models were adjusted 
for age, area, education, physical activity and smoking status. †Heterogeneity in estimates between males and females was assessed by Cochran’s Q test with 
fixed effects. ‡Apart from major dependent variables (e.g. hypertension) and major independent variables (e.g. alcohol intake), some variables included missing 
data points. 
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Table 6. Instrumental variable estimates of alcohol intake (g/day) to cardiovascular disease and risk factors, 
based on interaction of the rs671 genotype in ALDH2 and sex 
  All 
(N=7,152†) 
  OR (95% CI) 
by IV estimation* 
P-value 
Disease   
 Hypertension  1.031 (1.001, 1.062) 0.040 
 Cardiovascular disease  0.949 (0.988, 1.004) 0.362 
 Coronary heart disease  0.984 (0.886, 1.093) 0.762 
 Diabetes 1.045 (0.989, 1.104) 0.117 
 Beta coefficient (95% CI) 
by IV estimation* 
P-value 
Cardiovascular risk factor   
 Systolic blood pressure (mmHg) 0.202 (0.087, 0.317) 0.001 
 Diastolic blood pressure (mmHg) 0.100 (0.025, 0.175) 0.009 
 Body mass index (kg/m2) 0.004 (-0.017, 0.024) 0.732 
 Waist circumference (cm) 0.023 (-0.032, 0.078) 0.410 
 Hip circumference (cm) -0.025 (-0.061, 0.011) 0.179 
 Waist to hip ratio (continuous) 0.0005 (0.0001, 0.0009) 0.013 
 Log-transformed fasting blood glucose (log(mg/dL)) 0.0012 (0.0006, 0.0017) <0.0001 
 Total cholesterol (mg/dL) 0.038 (-0.197, 0.273) 0.750 
 HDL cholesterol (mg/dL) 0.166 (0.098, 0.233) <0.0001 
 LDL cholesterol (mg/dL) -0.362 (-0.578, -0.145) 0.001 
 Log-transformed triglycerides (log(mg/dL)) 0.003 (0.002, 0.005) <0.0001 
 
*OR and beta coefficients by IV estimation were obtained from instrumental variable regressions with a two 
stage least squares estimation method (in logistic regression models and in linear regression models, 
respectively), using interaction of rs671 genotype and sex as an instrument for alcohol intake. All regression 
models were adjusted for age, area, education, physical activity and smoking status. †Heterogeneity in 
estimates between males and females was assessed by Cochran’s Q test with fixed effects. ‡Apart from 
major dependent variables (e.g. hypertension) and major independent variables (e.g. alcohol intake), some 
variables included missing data points.  
